IP Library Granted Patent US 11,930,705
Granted Patent B2
US 11,930,705 · App. 17/775,900 · Granted Mar 12, 2024

Diaryloxybenzoheterodiazole compounds di-substituted with thienothiophenic groups

Inventors: Giuliana Schimperna (Novara, IT); Luigi Abbondanza (Novara, IT); Antonio Alfonso Proto (Novara, IT); Stefano Zanardi (Novara, IT)
Assignee: ENI S.P.A.
H10K85/6576C07D495/04H10K30/87H10K85/657
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,930,705
App. No.
17/775,900
Granted
Mar 12, 2024
Kind
B2
Abstract

There is a diaryloxybenzoheterodiazole compound di-substituted with thienothiophenic groups having general formula (Ia): The diaryloxybenzoheterodiazole compound di-substituted with thienothiophenic groups having general formula (Ia) can be advantageously used as a spectrum converter in luminescent solar concentrators (LSCS) capable, in turn, of improving the performance of photovoltaic devices (or solar devices), selected for example, between photovoltaic cells (or solar cells), photovoltaic modules (or solar modules), either on a rigid support, or on a flexible support. More particularly, said photovoltaic devices (or solar devices) can be advantageously used in the construction of greenhouses.

Claims (21)

1. The diaryloxybenzoheterodiazole compound disubstituted with thienothiophenic groups having general formula (Ia):

wherein

Z represents a sulphur atom, an oxygen atom, a selenium atom; or an NR 5 group wherein R 5 is selected from C 1 -C 20 alkyl groups, preferably C 1 -C 8 , linear or branched, or from optionally substituted aryl groups;

R 1 , R 2 and R 3 , equal to or different from each other, represent a hydrogen atom; or are selected from C 1 -C 20 alkyl groups, preferably C 1 -C 8 , linear or branched, optionally containing heteroatoms, optionally substituted cycloalkyl groups, optionally substituted aryl groups, C 1 -C 20 alkoxy groups, preferably C 1 -C 8 , linear or branched, optionally substituted, —COOR 6 groups wherein R 1 is selected from C 1 -C 20 alkyl groups, preferably C 1 -C 8 , linear or branched, or is a cyano group;

or R 1 and R 2 , may optionally be bound together so as to form, together with the carbon atoms to which they are bound, a saturated, unsaturated, or aromatic cycle or a polycyclic system containing from 3 to 14 carbon atoms, preferably from 4 to 6 carbon atoms, optionally containing one or more heteroatoms such as oxygen, sulfur, nitrogen, silicon, phosphorus, selenium;

N 4 , equal to or different from each other, are selected from optionally substituted aryl groups.

2. The diaryloxybenzoheterodiazole compound di-substituted with thienothiophenic groups according to claim 1 , wherein in said general formula (Ia):

Z represents a sulphur atom;

R 1 , equal to each other, represent a hydrogen atom; or are selected from optionally substituted aryl groups, preferably are 2,6-dimethylphenyl, 2-phenoxyphenyl, 2,4,6-triphenoxyphenyl;

R 2 and R 3 , equal to each other, represent a hydrogen atom;

R 4 is selected from optionally substituted aryl groups, preferably is phenyl.

3. A luminescent solar concentrator (LSC) including at least one diaryloxylbenzoheterodiazole compound di-substituted with thienothiophenic groups having a general formula (Ia) according to claim 1 or 2 .

4. A photovoltaic device or solar device comprising at least one photovoltaic cell or solar cell, and at least one luminescent solar concentrator (LSC) according to claim 3 .

5. Use of a photovoltaic device or solar device according to claim 4 in the construction of greenhouses.

6. The diaryloxybenzoheterodiazole compound di-substituted with thienothiophenic groups according to claim 1 , wherein the C 1 -C 20 alkyl groups of R 5 are selected from C 1 -C 8 alkyl groups.

7. The diaryloxybenzoheterodiazole compound di-substituted with thienothiophenic groups according to claim 1 , wherein the C 1 -C 2 alkyl groups of R 1 , R 2 or R3, are selected from C 1 -C 8 alkyl groups.

8. The diaryloxybenzoheterodiazole compound di-substituted with thienothiophenic groups according to claim 1 , wherein the C 1 -C 2 alkyl groups of R 6 are selected from C 1 -C 8 alkyl groups.

9. The diaryloxybenzoheterodiazole compound di-substituted with thienothiophenic groups according to claim 1 , wherein the aromatic cycle or polycyclic system.

10. The diaryloxybenzoheterodiazole compound di-substituted with thienothiophenic groups according to claim 1 , wherein the one or more heteroatoms of R 1 and R 2 are selected from the group consisting of oxygen, sulfur, nitrogen, silicon, phosphorus, and selenium.

11. The diaryloxybenzoheterodiazole compound di-substituted with thienothiophenic groups according to claim 2 , wherein the optionally substituted aryl groups of R 1 are selected from the group consisting of 2,6-dimethylphenyl, 2-phenoxyphenyl, and 2,4,6-triphenoxyphenyl.

12. The diaryloxybenzoheterodiazole compound di-substituted with thienothiophenic groups according to claim 2 , wherein the optionally substituted aryl groups of R4 are phenyl.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 30, 2023
From: SCHIMPERNA, GIULIANA; ABBONDANZA, LUIGI; PROTO, ANTONIO ALFONSO; ZANARDI, STEFANO
To: ENI S.P.A.
Reel/Frame 064133/0345 →
Priority Claims (1)
IT 102019000020970 · Nov 12, 2019 · national
Continuity (1)
Related Publication 20220399509A1 · Dec 15, 2022